Published in BMJ Open on November 24, 2016
Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use. Diabetes Ther (2017) 0.83
Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol). Diabetes Ther (2017) 0.78
Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us". Am J Public Health (2017) 0.75
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med (2015) 18.66
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med (2013) 11.34
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. START INVESTS P 13. N Engl J Med (2016) 7.04
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. Lancet (2015) 6.05
Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization. JAMA (1997) 6.00
Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care (2005) 5.99
The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol (2011) 5.55
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med (2002) 3.90
Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia (2006) 3.23
Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care (2013) 2.96
Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. Diabetes Care (2004) 2.80
Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care (2004) 2.78
Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care (2008) 2.52
The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care (2012) 2.33
Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK. Diabet Med (2007) 1.71
Rethinking the appraisal and approval of drugs for type 2 diabetes. BMJ (2015) 1.54
A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. Diabet Med (2010) 1.38
Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes. Diabet Med (2013) 1.32
Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study. Br J Gen Pract (2007) 1.25
Diabetes and ethnic minorities. Postgrad Med J (2005) 1.25
Miscoding, misclassification and misdiagnosis of diabetes in primary care. Diabet Med (2012) 1.24
The IMPROVE study--a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts. Int J Clin Pract (2008) 1.23
Refill adherence to oral hypoglycemic agents and glycemic control in veterans. Ann Pharmacother (2010) 1.10
Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes? Endocrine (2013) 1.09
Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea. Med Care (2011) 1.07
Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile. BMJ Open (2016) 1.06
The annual incidence of diabetic complications in a population of patients with Type 1 and Type 2 diabetes. Diabet Med (2005) 0.91
Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Curr Med Res Opin (2015) 0.90
U.S. emergency departments visits resulting from poor medication adherence: 2005-07. J Am Pharm Assoc (2003) (2013) 0.90
Basing approval of drugs for type 2 diabetes on real world outcomes. BMJ (2015) 0.85
Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study. BMC Nephrol (2013) 0.84
Infection risk in elderly people with reduced glycaemic control. Lancet Diabetes Endocrinol (2016) 0.79
Glucose test provenance recording in UK primary care: was that fasted or random? Diabet Med (2016) 0.77
Managing the evolving complexity of pharmacologic treatment: comparative effectiveness research, pharmacoeconomic data analyses, and other decision support tools. Am J Manag Care (2012) 0.77
Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile. BMJ Open (2016) 1.06
Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use. Diabetes Ther (2017) 0.83
Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol). Diabetes Ther (2017) 0.78
Patients' experiences of consultations with physician associates in primary care in England: A qualitative study. Health Expect (2017) 0.75
Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes? Diabetes Ther (2020) 0.75
Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: protocol of a pilot study in England. BMJ Open (2017) 0.75